Deucravacitinib in concomitant psoriasis vulgaris and bullous pemphigoid: A case of sustained dual disease control.

Sotyktu (deucravacitinib) - BMS

Deucravacitinib in concomitant psoriasis vulgaris and bullous pemphigoid: A case of sustained dual disease control. (PubMed, JAAD Case Rep) - Oct 15, 2026 - No abstract available
Journal • Bullous Pemphigoid • Dermatology • Dermatopathology • Immunology • Psoriasis

http://www.ncbi.nlm.nih.gov/pubmed/42871554

Alessandro Magnatta; Alice Verdelli; Irene Bonanni; Luca Sanna; Marta Donati; Marzia Caproni; Rachel Daher; Simone Landini; Virginia Corti; Walter Volpi

Oct 15, 2026